| Serial Number | 97347635 |
| Word Mark | MRNATE |
| Filing Date | Tuesday, April 5, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Thursday, June 6, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 9, 2023 |
| Goods and Services | Vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viral diseases and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations for intracellular delivery of self-amplifying messenger RNA (sa-mRNA) for preventing and treating viral diseases all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells |
| Goods and Services | Active biological ingredients for use in the manufacture of pharmaceuticals, namely, self-amplifying messenger RNA (sa-mRNA) encapsulated in a lipid nanoparticle composed of a cationic lipid and three helper lipids for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses and respiratory disorders; biochemicals for in vivo, ex vivo, on vivo or in vitro scientific research; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; lipid nanoparticles for scientific, laboratory or medical research use |
| Goods and Services | Medical services; medical information; providing a website featuring medical information |
| Goods and Services | Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 5, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 5, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 11, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, April 11, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Seqirus Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Holly Springs, NC 27540 |
| Party Name | Seqirus Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Holly Springs, NC 27540 |
| Event Date | Event Description |
| Friday, April 8, 2022 | NEW APPLICATION ENTERED |
| Monday, April 11, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 23, 2023 | ASSIGNED TO EXAMINER |
| Friday, January 27, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, January 27, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, January 27, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, March 21, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 21, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, March 22, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 5, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, April 5, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 5, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, April 5, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, April 5, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 19, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 9, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 9, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 4, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, December 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, December 19, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, December 19, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, December 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, June 6, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 6, 2024 | SOU EXTENSION 2 FILED |
| Thursday, June 6, 2024 | SOU EXTENSION 2 GRANTED |
| Thursday, June 13, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |